BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30664797)

  • 1. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
    Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
    Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
    Liu H; Pathak P; Boehme S; Chiang JL
    J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
    Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
    J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acid Homeostasis in a Cholesterol 7α-Hydroxylase and Sterol 27-Hydroxylase Double Knockout Mouse Model.
    Rizzolo D; Buckley K; Kong B; Zhan L; Shen J; Stofan M; Brinker A; Goedken M; Buckley B; Guo GL
    Hepatology; 2019 Jul; 70(1):389-402. PubMed ID: 30864232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.
    Wang XX; Xie C; Libby AE; Ranjit S; Levi J; Myakala K; Bhasin K; Jones BA; Orlicky DJ; Takahashi S; Dvornikov A; Kleiner DE; Hewitt SM; Adorini L; Kopp JB; Krausz KW; Rosenberg A; McManaman JL; Robertson CE; Ir D; Frank DN; Luo Y; Gonzalez FJ; Gratton E; Levi M
    J Biol Chem; 2022 Nov; 298(11):102530. PubMed ID: 36209823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
    Miyata M; Tanaka T; Takahashi K; Funaki A; Sugiura Y
    Amino Acids; 2021 Oct; 53(10):1523-1532. PubMed ID: 34596761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
    Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of SHP-null mice to bile acid-induced liver damage.
    Wang L; Han Y; Kim CS; Lee YK; Moore DD
    J Biol Chem; 2003 Nov; 278(45):44475-81. PubMed ID: 12933814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice.
    Li-Hawkins J; Gåfvels M; Olin M; Lund EG; Andersson U; Schuster G; Björkhem I; Russell DW; Eggertsen G
    J Clin Invest; 2002 Oct; 110(8):1191-200. PubMed ID: 12393855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model.
    Taylor R; Yang Z; Henry Z; Capece G; Meadows V; Otersen K; Basaly V; Bhattacharya A; Mera S; Zhou P; Joseph L; Yang I; Brinker A; Buckley B; Kong B; Guo GL
    Toxicol Sci; 2024 May; 199(2):316-331. PubMed ID: 38526215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
    Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
    Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.
    Xu G; Pan LX; Li H; Shang Q; Honda A; Shefer S; Bollineni J; Matsuzaki Y; Tint GS; Salen G
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G730-5. PubMed ID: 14684380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.